<code id='ECDDC4ADE1'></code><style id='ECDDC4ADE1'></style>
      • <acronym id='ECDDC4ADE1'></acronym>
      <center id='ECDDC4ADE1'><center id='ECDDC4ADE1'><tfoot id='ECDDC4ADE1'></tfoot></center><abbr id='ECDDC4ADE1'><dir id='ECDDC4ADE1'><tfoot id='ECDDC4ADE1'></tfoot><noframes id='ECDDC4ADE1'>
      • <optgroup id='ECDDC4ADE1'><strike id='ECDDC4ADE1'><sup id='ECDDC4ADE1'></sup></strike><code id='ECDDC4ADE1'></code></optgroup>
        5. <b id='ECDDC4ADE1'><label id='ECDDC4ADE1'><select id='ECDDC4ADE1'><dt id='ECDDC4ADE1'><span id='ECDDC4ADE1'></span></dt></select></label></b><u id='ECDDC4ADE1'></u>
          <i id='ECDDC4ADE1'><strike id='ECDDC4ADE1'><tt id='ECDDC4ADE1'><pre id='ECDDC4ADE1'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-28 19:23:53 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：718
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Grail spinoff by Illumina should end disastrous merger attempt
                                
                            
          Next article：  
                                      
                                          Medicare proposal to cover medical devices draws a mixed reaction
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles